Clinical Trials · NCT05064735
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 407
- Start date
- Oct 2021
- Locations
- 122 sites, 11 countries
- Primary endpoint
- Percentage Change in Body Weight